What’s Next For Ionis Pharmaceuticals Stock After A 14% Fall?

What’s Next For Ionis Pharmaceuticals Stock After A 14% Fall?

The stock price of Ionis Pharmaceuticals, a biotech company that specializes in discovering and developing RNA-targeted therapeutics, plunged 14% in yesterday’s trade to its five year low levels of $30, while it is down 19% over the last one month…